ABOUT
James Yates is Scientific Director at GSK and leads the nonclinical PKPD modelling team. He has a background in mathematics and engineering (University of Warwick, UK) and has 18 years’ experience in drug discovery and development, particularly in oncology. He has published over 80 papers on translational PKPD. He has a particular interest in the application of mathematical modelling for translation from nonclinical to patients and between patient populations.